Cohance Lifesciences Limited (BOM:543064)
949.95
+8.70 (0.92%)
At close: Aug 12, 2025
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 377.23 billion as of August 13, 2025. Its market cap has increased by 59.61% in one year.
Market Cap
377.23B
Enterprise Value
378.66B
Revenue
11.98B
Ranking
n/a
PE Ratio
140.83
Stock Price
949.95
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 377.23B, an increase of 1,119,111.77%. That is a compound annual growth rate of 456.72%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 12, 2025 | 363.73B | 25.47% |
Dec 31, 2024 | 289.89B | 57.55% |
Dec 29, 2023 | 184.00B | 46.05% |
Dec 30, 2022 | 125.98B | 0.33% |
Dec 31, 2021 | 125.56B | 9.05% |
Dec 31, 2020 | 115.14B | 341,510.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Reliance Industries | 18.68T |
HDFC Bank | 15.12T |
Bharti Airtel | 11.09T |
Tata Consultancy Services | 10.98T |
ICICI Bank | 10.15T |
State Bank of India | 7,574.64B |
Infosys | 5,916.24B |
Hindustan Unilever | 5,835.91B |